Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanisms and Predictors of Lorcaserin-Induced Weight Loss
NCT03353220Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Jan 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and Overweight comparing Lorcaserin First with Placebo First (2 arms). Primary endpoints: Mean Differences in Food Intake During a Laboratory Test Meal up to 5 weeks and Mean Differences in POMC Concentrations in CSF up to 5 weeks. Started Jan 2018; status: terminated.
02
Drugs
lorcaserin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT03353220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03353220.